Autolus Therapeutics Stock (NASDAQ:AUTL), Quotes and News Summary
Autolus Therapeutics Stock (NASDAQ: AUTL) stock price, news, charts, stock research, profile.
| Day Range- - - | 52 Wk Range1.600 - 5.040 | Open / Close- / - | Float / Outstanding- / 173.059M |
| Vol / Avg.0 / 627.863K | Mkt Cap358.233M | P/E- | 50d Avg. Price2.120 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.850 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-03-09 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.470 | ||||||
| REV | 2.369M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Autolus Therapeutics (AUTL) stock?
You can purchase shares of Autolus Therapeutics (NASDAQ: AUTL) through any online brokerage.
Who are Autolus Therapeutics's (AUTL) competitors?
Other companies in Autolus Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Outlook Therapeutics (NASDAQ:OTLK), Cabaletta Bio (NASDAQ:CABA), Humacyte (NASDAQ:HUMA) and Voyager Therapeutics (NASDAQ:VYGR).
What is the target price for Autolus Therapeutics (AUTL) stock?
The latest price target for Autolus Therapeutics (NASDAQ: AUTL) was reported by Needham on Friday, December 9, 2022. The analyst firm set a price target for 7.00 expecting AUTL to rise to within 12 months (a possible 238.16% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Autolus Therapeutics (AUTL)?
The stock price for Autolus Therapeutics (NASDAQ: AUTL) is $2.07 last updated February 2, 2023 at 9:00 PM UTC.
Does Autolus Therapeutics (AUTL) pay a dividend?
There are no upcoming dividends for Autolus Therapeutics.
When is Autolus Therapeutics (NASDAQ:AUTL) reporting earnings?
Autolus Therapeutics’s Q4 earnings are confirmed for Thursday, March 9, 2023.
Is Autolus Therapeutics (AUTL) going to split?
There is no upcoming split for Autolus Therapeutics.
What sector and industry does Autolus Therapeutics (AUTL) operate in?
Autolus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Autolus Therapeutics Stock (NASDAQ:AUTL), Quotes and News Summary
Autolus Therapeutics Stock (NASDAQ: AUTL) stock price, news, charts, stock research, profile.
| Day Range- - - | 52 Wk Range1.600 - 5.040 | Open / Close- / - | Float / Outstanding- / 173.059M |
| Vol / Avg.0 / 627.863K | Mkt Cap358.233M | P/E- | 50d Avg. Price2.120 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.850 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-03-09 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.470 | ||||||
| REV | 2.369M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Autolus Therapeutics (AUTL) stock?
You can purchase shares of Autolus Therapeutics (NASDAQ: AUTL) through any online brokerage.
Who are Autolus Therapeutics's (AUTL) competitors?
Other companies in Autolus Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Outlook Therapeutics (NASDAQ:OTLK), Cabaletta Bio (NASDAQ:CABA), Humacyte (NASDAQ:HUMA) and Voyager Therapeutics (NASDAQ:VYGR).
What is the target price for Autolus Therapeutics (AUTL) stock?
The latest price target for Autolus Therapeutics (NASDAQ: AUTL) was reported by Needham on Friday, December 9, 2022. The analyst firm set a price target for 7.00 expecting AUTL to rise to within 12 months (a possible 238.16% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Autolus Therapeutics (AUTL)?
The stock price for Autolus Therapeutics (NASDAQ: AUTL) is $2.07 last updated February 2, 2023 at 9:00 PM UTC.
Does Autolus Therapeutics (AUTL) pay a dividend?
There are no upcoming dividends for Autolus Therapeutics.
When is Autolus Therapeutics (NASDAQ:AUTL) reporting earnings?
Autolus Therapeutics’s Q4 earnings are confirmed for Thursday, March 9, 2023.
Is Autolus Therapeutics (AUTL) going to split?
There is no upcoming split for Autolus Therapeutics.
What sector and industry does Autolus Therapeutics (AUTL) operate in?
Autolus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Autolus Therapeutics Stock (NASDAQ:AUTL), Quotes and News Summary
Autolus Therapeutics Stock (NASDAQ: AUTL) stock price, news, charts, stock research, profile.
| Day Range- - - | 52 Wk Range1.600 - 5.040 | Open / Close- / - | Float / Outstanding- / 173.059M |
| Vol / Avg.0 / 627.863K | Mkt Cap358.233M | P/E- | 50d Avg. Price2.120 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.850 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-03-09 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.470 | ||||||
| REV | 2.369M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Autolus Therapeutics (AUTL) stock?
You can purchase shares of Autolus Therapeutics (NASDAQ: AUTL) through any online brokerage.
Who are Autolus Therapeutics's (AUTL) competitors?
Other companies in Autolus Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Outlook Therapeutics (NASDAQ:OTLK), Cabaletta Bio (NASDAQ:CABA), Humacyte (NASDAQ:HUMA) and Voyager Therapeutics (NASDAQ:VYGR).
What is the target price for Autolus Therapeutics (AUTL) stock?
The latest price target for Autolus Therapeutics (NASDAQ: AUTL) was reported by Needham on Friday, December 9, 2022. The analyst firm set a price target for 7.00 expecting AUTL to rise to within 12 months (a possible 238.16% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Autolus Therapeutics (AUTL)?
The stock price for Autolus Therapeutics (NASDAQ: AUTL) is $2.07 last updated February 2, 2023 at 9:00 PM UTC.
Does Autolus Therapeutics (AUTL) pay a dividend?
There are no upcoming dividends for Autolus Therapeutics.
When is Autolus Therapeutics (NASDAQ:AUTL) reporting earnings?
Autolus Therapeutics’s Q4 earnings are confirmed for Thursday, March 9, 2023.
Is Autolus Therapeutics (AUTL) going to split?
There is no upcoming split for Autolus Therapeutics.
What sector and industry does Autolus Therapeutics (AUTL) operate in?
Autolus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Autolus Therapeutics Stock (NASDAQ:AUTL), Quotes and News Summary
Autolus Therapeutics Stock (NASDAQ: AUTL) stock price, news, charts, stock research, profile.
| Day Range- - - | 52 Wk Range1.600 - 5.040 | Open / Close- / - | Float / Outstanding- / 173.059M |
| Vol / Avg.0 / 627.863K | Mkt Cap358.233M | P/E- | 50d Avg. Price2.120 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.850 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-03-09 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.470 | ||||||
| REV | 2.369M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Autolus Therapeutics (AUTL) stock?
You can purchase shares of Autolus Therapeutics (NASDAQ: AUTL) through any online brokerage.
Who are Autolus Therapeutics's (AUTL) competitors?
Other companies in Autolus Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Outlook Therapeutics (NASDAQ:OTLK), Cabaletta Bio (NASDAQ:CABA), Humacyte (NASDAQ:HUMA) and Voyager Therapeutics (NASDAQ:VYGR).
What is the target price for Autolus Therapeutics (AUTL) stock?
The latest price target for Autolus Therapeutics (NASDAQ: AUTL) was reported by Needham on Friday, December 9, 2022. The analyst firm set a price target for 7.00 expecting AUTL to rise to within 12 months (a possible 238.16% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Autolus Therapeutics (AUTL)?
The stock price for Autolus Therapeutics (NASDAQ: AUTL) is $2.07 last updated February 2, 2023 at 9:00 PM UTC.
Does Autolus Therapeutics (AUTL) pay a dividend?
There are no upcoming dividends for Autolus Therapeutics.
When is Autolus Therapeutics (NASDAQ:AUTL) reporting earnings?
Autolus Therapeutics’s Q4 earnings are confirmed for Thursday, March 9, 2023.
Is Autolus Therapeutics (AUTL) going to split?
There is no upcoming split for Autolus Therapeutics.
What sector and industry does Autolus Therapeutics (AUTL) operate in?
Autolus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Autolus Therapeutics Stock (NASDAQ:AUTL), Quotes and News Summary
Autolus Therapeutics Stock (NASDAQ: AUTL) stock price, news, charts, stock research, profile.
| Day Range- - - | 52 Wk Range1.600 - 5.040 | Open / Close- / - | Float / Outstanding- / 173.059M |
| Vol / Avg.0 / 627.863K | Mkt Cap358.233M | P/E- | 50d Avg. Price2.120 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.850 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-03-09 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.470 | ||||||
| REV | 2.369M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Autolus Therapeutics (AUTL) stock?
You can purchase shares of Autolus Therapeutics (NASDAQ: AUTL) through any online brokerage.
Who are Autolus Therapeutics's (AUTL) competitors?
Other companies in Autolus Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Outlook Therapeutics (NASDAQ:OTLK), Cabaletta Bio (NASDAQ:CABA), Humacyte (NASDAQ:HUMA) and Voyager Therapeutics (NASDAQ:VYGR).
What is the target price for Autolus Therapeutics (AUTL) stock?
The latest price target for Autolus Therapeutics (NASDAQ: AUTL) was reported by Needham on Friday, December 9, 2022. The analyst firm set a price target for 7.00 expecting AUTL to rise to within 12 months (a possible 238.16% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Autolus Therapeutics (AUTL)?
The stock price for Autolus Therapeutics (NASDAQ: AUTL) is $2.07 last updated February 2, 2023 at 9:00 PM UTC.
Does Autolus Therapeutics (AUTL) pay a dividend?
There are no upcoming dividends for Autolus Therapeutics.
When is Autolus Therapeutics (NASDAQ:AUTL) reporting earnings?
Autolus Therapeutics’s Q4 earnings are confirmed for Thursday, March 9, 2023.
Is Autolus Therapeutics (AUTL) going to split?
There is no upcoming split for Autolus Therapeutics.
What sector and industry does Autolus Therapeutics (AUTL) operate in?
Autolus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Autolus Therapeutics Stock (NASDAQ:AUTL), Quotes and News Summary
Autolus Therapeutics Stock (NASDAQ: AUTL) stock price, news, charts, stock research, profile.
| Day Range- - - | 52 Wk Range1.600 - 5.040 | Open / Close- / - | Float / Outstanding- / 173.059M |
| Vol / Avg.0 / 627.863K | Mkt Cap358.233M | P/E- | 50d Avg. Price2.120 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.850 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-03-09 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.470 | ||||||
| REV | 2.369M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Autolus Therapeutics (AUTL) stock?
You can purchase shares of Autolus Therapeutics (NASDAQ: AUTL) through any online brokerage.
Who are Autolus Therapeutics's (AUTL) competitors?
Other companies in Autolus Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Outlook Therapeutics (NASDAQ:OTLK), Cabaletta Bio (NASDAQ:CABA), Humacyte (NASDAQ:HUMA) and Voyager Therapeutics (NASDAQ:VYGR).
What is the target price for Autolus Therapeutics (AUTL) stock?
The latest price target for Autolus Therapeutics (NASDAQ: AUTL) was reported by Needham on Friday, December 9, 2022. The analyst firm set a price target for 7.00 expecting AUTL to rise to within 12 months (a possible 238.16% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Autolus Therapeutics (AUTL)?
The stock price for Autolus Therapeutics (NASDAQ: AUTL) is $2.07 last updated February 2, 2023 at 9:00 PM UTC.
Does Autolus Therapeutics (AUTL) pay a dividend?
There are no upcoming dividends for Autolus Therapeutics.
When is Autolus Therapeutics (NASDAQ:AUTL) reporting earnings?
Autolus Therapeutics’s Q4 earnings are confirmed for Thursday, March 9, 2023.
Is Autolus Therapeutics (AUTL) going to split?
There is no upcoming split for Autolus Therapeutics.
What sector and industry does Autolus Therapeutics (AUTL) operate in?
Autolus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Autolus Therapeutics Stock (NASDAQ:AUTL), Quotes and News Summary
Autolus Therapeutics Stock (NASDAQ: AUTL) stock price, news, charts, stock research, profile.
| Day Range- - - | 52 Wk Range1.600 - 5.040 | Open / Close- / - | Float / Outstanding- / 173.059M |
| Vol / Avg.0 / 627.863K | Mkt Cap358.233M | P/E- | 50d Avg. Price2.120 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.850 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-03-09 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.470 | ||||||
| REV | 2.369M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Autolus Therapeutics (AUTL) stock?
You can purchase shares of Autolus Therapeutics (NASDAQ: AUTL) through any online brokerage.
Who are Autolus Therapeutics's (AUTL) competitors?
Other companies in Autolus Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Outlook Therapeutics (NASDAQ:OTLK), Cabaletta Bio (NASDAQ:CABA), Humacyte (NASDAQ:HUMA) and Voyager Therapeutics (NASDAQ:VYGR).
What is the target price for Autolus Therapeutics (AUTL) stock?
The latest price target for Autolus Therapeutics (NASDAQ: AUTL) was reported by Needham on Friday, December 9, 2022. The analyst firm set a price target for 7.00 expecting AUTL to rise to within 12 months (a possible 238.16% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Autolus Therapeutics (AUTL)?
The stock price for Autolus Therapeutics (NASDAQ: AUTL) is $2.07 last updated February 2, 2023 at 9:00 PM UTC.
Does Autolus Therapeutics (AUTL) pay a dividend?
There are no upcoming dividends for Autolus Therapeutics.
When is Autolus Therapeutics (NASDAQ:AUTL) reporting earnings?
Autolus Therapeutics’s Q4 earnings are confirmed for Thursday, March 9, 2023.
Is Autolus Therapeutics (AUTL) going to split?
There is no upcoming split for Autolus Therapeutics.
What sector and industry does Autolus Therapeutics (AUTL) operate in?
Autolus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Autolus Therapeutics Stock (NASDAQ:AUTL), Quotes and News Summary
Autolus Therapeutics Stock (NASDAQ: AUTL) stock price, news, charts, stock research, profile.
| Day Range- - - | 52 Wk Range1.600 - 5.040 | Open / Close- / - | Float / Outstanding- / 173.059M |
| Vol / Avg.0 / 627.863K | Mkt Cap358.233M | P/E- | 50d Avg. Price2.120 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.850 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-03-09 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.470 | ||||||
| REV | 2.369M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Autolus Therapeutics (AUTL) stock?
You can purchase shares of Autolus Therapeutics (NASDAQ: AUTL) through any online brokerage.
Who are Autolus Therapeutics's (AUTL) competitors?
Other companies in Autolus Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Outlook Therapeutics (NASDAQ:OTLK), Cabaletta Bio (NASDAQ:CABA), Humacyte (NASDAQ:HUMA) and Voyager Therapeutics (NASDAQ:VYGR).
What is the target price for Autolus Therapeutics (AUTL) stock?
The latest price target for Autolus Therapeutics (NASDAQ: AUTL) was reported by Needham on Friday, December 9, 2022. The analyst firm set a price target for 7.00 expecting AUTL to rise to within 12 months (a possible 238.16% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Autolus Therapeutics (AUTL)?
The stock price for Autolus Therapeutics (NASDAQ: AUTL) is $2.07 last updated February 2, 2023 at 9:00 PM UTC.
Does Autolus Therapeutics (AUTL) pay a dividend?
There are no upcoming dividends for Autolus Therapeutics.
When is Autolus Therapeutics (NASDAQ:AUTL) reporting earnings?
Autolus Therapeutics’s Q4 earnings are confirmed for Thursday, March 9, 2023.
Is Autolus Therapeutics (AUTL) going to split?
There is no upcoming split for Autolus Therapeutics.
What sector and industry does Autolus Therapeutics (AUTL) operate in?
Autolus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Autolus Therapeutics Stock (NASDAQ:AUTL), Quotes and News Summary
Autolus Therapeutics Stock (NASDAQ: AUTL) stock price, news, charts, stock research, profile.
| Day Range- - - | 52 Wk Range1.600 - 5.040 | Open / Close- / - | Float / Outstanding- / 173.059M |
| Vol / Avg.0 / 627.863K | Mkt Cap358.233M | P/E- | 50d Avg. Price2.120 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-1.850 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-03-09 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.470 | ||||||
| REV | 2.369M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Autolus Therapeutics (AUTL) stock?
You can purchase shares of Autolus Therapeutics (NASDAQ: AUTL) through any online brokerage.
Who are Autolus Therapeutics's (AUTL) competitors?
Other companies in Autolus Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Outlook Therapeutics (NASDAQ:OTLK), Cabaletta Bio (NASDAQ:CABA), Humacyte (NASDAQ:HUMA) and Voyager Therapeutics (NASDAQ:VYGR).
What is the target price for Autolus Therapeutics (AUTL) stock?
The latest price target for Autolus Therapeutics (NASDAQ: AUTL) was reported by Needham on Friday, December 9, 2022. The analyst firm set a price target for 7.00 expecting AUTL to rise to within 12 months (a possible 238.16% upside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for Autolus Therapeutics (AUTL)?
The stock price for Autolus Therapeutics (NASDAQ: AUTL) is $2.07 last updated February 2, 2023 at 9:00 PM UTC.
Does Autolus Therapeutics (AUTL) pay a dividend?
There are no upcoming dividends for Autolus Therapeutics.
When is Autolus Therapeutics (NASDAQ:AUTL) reporting earnings?
Autolus Therapeutics’s Q4 earnings are confirmed for Thursday, March 9, 2023.
Is Autolus Therapeutics (AUTL) going to split?
There is no upcoming split for Autolus Therapeutics.
What sector and industry does Autolus Therapeutics (AUTL) operate in?
Autolus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.